Schedule 13G ownership disclosure

INVIVO THERAPEUTICS HOLDINGS CORP.

Security class unavailable · CUSIP: 46186M100

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
507,100
Percent of class
1.8500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-16-000108
Form type
SC 13G/A
Filer
INVIVO THERAPEUTICS HOLDINGS CORP.
CIK
CIK 1292519
Filed
Jan 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub